WeVote
Log In

Bill

Bill

A 2250

Relates to breast cancer screening and diagnostic testing for incarcerated individuals in accordance with certain nationally recognized clinical practice guidelines

2025 Regular Session Introduced by Jessica González-Rojas and 2 co-sponsors

Requires breast cancer screening and diagnostic testing for incarcerated individuals, aligned with national clinical guidelines, to improve early detection and care in prisons.

SIGNED CHAP.67
0
WeVote Research Nonpartisan
Bill Summary · A 2250

Summary of New York A 2250 (Chapter 67, 2025)

Overview

A 2250, titled Relates to breast cancer screening and diagnostic testing for incarcerated individuals in accordance with certain nationally recognized clinical practice guidelines, has been enacted and signed into law as Chapter 67 of 2025. The bill, introduced January 15, 2025, moved through the Legislature in February and was signed by the governor in mid-February 2025.

Purpose and Intent

  • To ensure that incarcerated individuals receive breast cancer screening and diagnostic testing in line with nationally recognized clinical practice guidelines.
  • Aims to standardize access to preventive and diagnostic breast care within correctional settings, promoting early detection and appropriate follow-up care.

Key Provisions (What the Bill Would Do)

  • Mandate breast cancer screening and diagnostic testing for incarcerated individuals.
  • Require that screening and testing be conducted in accordance with nationally recognized clinical practice guidelines (e.g., guidelines developed by major health authorities or professional associations).
  • Establish that health care services within correctional facilities must align with quality and consistency standards set forth by the act.
  • Implicitly create a framework for scheduling, delivery, and follow-up of breast cancer screening and diagnostic testing within correctional health care.

Note: The available summary does not include line-by-line text or explicit details on frequency, age thresholds, specific tests (e.g., mammography, clinical breast exam), consent, documentation, confidentiality, or funding mechanisms. The provisions are described at a high level as aligning screening and diagnostic testing with nationally recognized guidelines.

Who Is Affected

  • Incarcerated individuals residing in state correctional facilities.
  • Correctional health care providers and administrators responsible for delivering medical services.
  • State agencies overseeing corrections and health care delivery within prisons/jails.

Implementation Timeline and Procedures

  • Enacted as Chapter 67 (signed into law) in February 2025.
  • The bill followed a standard legislative path: introduction, committee referrals, passage in both chambers (Assembly and Senate) in early February 2025, and gubernatorial approval in mid-February 2025.
  • Related legislation cited: S 768 (prior-session and companion versions), indicating a continuity of related proposals.

Legislative History and Related Bills

  • Related: S 768 (prior-session) and companion versions.
  • The bill originated as A 2250 and was substituted for S 768 at a late stage in the legislative process, then moved through to passage and signature.

Potential Impact and Considerations

  • Improved early detection of breast cancer among incarcerated individuals.
  • Consistency with clinical guidelines may enhance quality and equity of health care within correctional facilities.
  • Implementation considerations may include funding, training for correctional health staff, access to diagnostic services, and coordination with external health care providers for follow-up care.

If you’d like, I can add a brief comparison to how similar screening requirements are implemented in other jurisdictions or outline potential fiscal implications based on typical correctional health care budgets.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.